| The tomato genome sequence provides insights into fleshy fruit evolution xx Tomato Genome Consortium Nature 485 (7400), 635, 2012 | 3375 | 2012 |
| Comprehensive analysis of hypermutation in human cancer BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ... Cell 171 (5), 1042-1056. e10, 2017 | 770 | 2017 |
| Diversity of bifidobacteria within the infant gut microbiota F Turroni, C Peano, DA Pass, E Foroni, M Severgnini, MJ Claesson, ... PloS one 7 (5), e36957, 2012 | 769 | 2012 |
| Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition MR Sapienza, F Fuligni, C Agostinelli, C Tripodo, S Righi, MA Laginestra, ... Leukemia 28 (8), 1606-1616, 2014 | 184 | 2014 |
| Distinct viral and mutational spectrum of endemic Burkitt lymphoma F Abate, MR Ambrosio, L Mundo, MA Laginestra, F Fuligni, M Rossi, ... PLoS pathogens 11 (10), e1005158, 2015 | 179 | 2015 |
| Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors ND Anderson, R de Borja, MD Young, F Fuligni, A Rosic, ND Roberts, ... Science 361 (6405), eaam8419, 2018 | 166 | 2018 |
| Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study PP Piccaluga, F Fuligni, A De Leo, C Bertuzzi, M Rossi, F Bacci, ... Journal of Clinical Oncology 31 (24), 3019-3025, 2013 | 145 | 2013 |
| Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma S Sangaletti, C Tripodo, C Vitali, P Portararo, C Guarnotta, P Casalini, ... Cancer discovery 4 (1), 110-129, 2014 | 135 | 2014 |
| Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target MR Sapienza, F Abate, F Melle, S Orecchioni, F Fuligni, M Etebari, ... haematologica 104 (4), 729, 2018 | 78 | 2018 |
| The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies A Gazzola, C Mannu, M Rossi, MA Laginestra, MR Sapienza, F Fuligni, ... Therapeutic advances in hematology 5 (2), 35-47, 2014 | 73 | 2014 |
| Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma E Derenzini, C Agostinelli, E Imbrogno, I Iacobucci, B Casadei, ... Oncotarget 6 (9), 6553, 2015 | 71 | 2015 |
| The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations A Villani, S Davidson, N Kanwar, WW Lo, Y Li, S Cohen-Gogo, F Fuligni, ... Nature cancer 4 (2), 203-221, 2023 | 69 | 2023 |
| The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study C Agostinelli, A Gallamini, L Stracqualursi, P Agati, C Tripodo, F Fuligni, ... The Lancet Haematology 3 (10), e467-e479, 2016 | 69 | 2016 |
| The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma E Marchi, KM Zullo, JE Amengual, M Kalac, D Bongero, CM McIntosh, ... British journal of haematology 171 (2), 215-226, 2015 | 66 | 2015 |
| SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias C Vitali, C Bassani, C Chiodoni, E Fellini, C Guarnotta, S Miotti, ... Cancer research 75 (11), 2387-2399, 2015 | 58 | 2015 |
| Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified MA Laginestra, L Cascione, G Motta, F Fuligni, C Agostinelli, M Rossi, ... Modern Pathology 33 (2), 179-187, 2020 | 57 | 2020 |
| Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival ND Anderson, Y Babichev, F Fuligni, F Comitani, M Layeghifard, ... Nature communications 12 (1), 4496, 2021 | 53 | 2021 |
| Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas PP Piccaluga, M Navari, G De Falco, MR Ambrosio, S Lazzi, F Fuligni, ... Oncotarget 7 (1), 224, 2015 | 52 | 2015 |
| Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway PP Piccaluga, M Rossi, C Agostinelli, F Ricci, A Gazzola, S Righi, ... Leukemia 28 (8), 1687-1697, 2014 | 51 | 2014 |
| Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma G Franco, C Guarnotta, B Frossi, PP Piccaluga, E Boveri, A Gulino, ... Blood, The Journal of the American Society of Hematology 123 (12), 1836-1849, 2014 | 48 | 2014 |
Pileri Stefano A.IEO IRCCS, Research Advisor, Milan; Former Full-Professor of Pathology, Bologna UniversityZweryfikowany adres z unibo.it